Evidence, Safety, and the Regulatory Landscape GLP-1 microdosing is biologically plausible, but its safety and effectiveness have not been validated in randomized clinical trials
We recognize the important roles that pharmaceutical compounding and telehealth play in the health care delivery system, helping to ensure access to FDA-approved products and filling a need for more customized treatments, Durbin and Marshall wrote
Clinical trials and real-world data show no direct negative impact of GLP-1 agonists on fertility, menstrual function, or pregnancy success rates
Board Certified in Anti-Aging & Regenerative Medicine Fellowship trained by Dr
Scully, T., Ettela, A., LeRoith, D., Gallagher, E
[15] Always feel free to discuss with your provider why NAD+ is recommended in your case and what the current evidence is, since it is a newer therapy outside of standard FDA-approved treatments